Comment on “Glioblastoma patients’ survival and its relevant risk factors during the pre- and post-COVID-19 pandemic: Real-world cohort study in the USA and China”

aDepartment of Pulmonary and Critical Care Medicine, Zhujiang Hospital of Southern Medical University, 253 Industrial Avenue, Guangzhou, Guangdong 510282, China bDepartment of Oncology, Zhujiang Hospital of Southern Medical University, 253 Industrial Avenue, Guangzhou, Guangdong 510282, China Running title: The COVID-19 pandemic influences cancer survival. Chaofan Fan, Peng Luo Contributed equally to this work. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Published online ■ ■ *Corresponding author. Address: Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital of Southern Medical University, 253 Industrial Avenue, Guangzhou, Guangdong 510282, China. E-mail address: [email protected] (X. Chen). This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/